Can You Take Etripamil with PNV 27-Ca/Fe/FA?

Food may reduce the absorption and blood levels of multivitamin, prenatal. In addition, some oral medications can also interfere with multivitamin, prenatal absorption into the bloodstream, which may make the medication less effective in treating your condition. Likewise, multivitamin, prenatal may interfere with the absorption of other orally administered medications. You should take multivitamin, prenatal on an empty stomach at least one hour before or two hours after a meal. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. Talk to your doctor or pharmacist if you have questions about how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Etripamil is contraindicated in patients with heart failure (NYHA Class II to IV), Wolff-Parkinson-White syndrome, Lown-Ganong-Levine syndromes, manifest pre-excitation (delta wave) on a 12-lead ECG, sick sinus syndrome without a permanent pacemaker, or second degree atrioventricular (AV) Mobitz 2 block or higher degree of AV block. When initiating therapy with etripamil, patients with a history of hypotensive episodes or those at increased risk for hemodynamic instability should be monitored appropriately. Etripamil may cause dizziness and/or syncope, especially in patients with a history of syncope and high-grade AV block or sinus node dysfunction, or those with a history of syncope during an episode of paroxysmal supraventricular tachycardia.

Etripamil is contraindicated in patients with heart failure (NYHA Class II to IV), Wolff-Parkinson-White syndrome, Lown-Ganong-Levine syndromes, manifest pre-excitation (delta wave) on a 12-lead ECG, sick sinus syndrome without a permanent pacemaker, or second degree atrioventricular (AV) Mobitz 2 block or higher degree of AV block. When initiating therapy with etripamil, patients with a history of hypotensive episodes or those at increased risk for hemodynamic instability should be monitored appropriately. Etripamil may cause dizziness and/or syncope, especially in patients with a history of syncope and high-grade AV block or sinus node dysfunction, or those with a history of syncope during an episode of paroxysmal supraventricular tachycardia.

Etripamil is contraindicated in patients with heart failure (NYHA Class II to IV), Wolff-Parkinson-White syndrome, Lown-Ganong-Levine syndromes, manifest pre-excitation (delta wave) on a 12-lead ECG, sick sinus syndrome without a permanent pacemaker, or second degree atrioventricular (AV) Mobitz 2 block or higher degree of AV block. When initiating therapy with etripamil, patients with a history of hypotensive episodes or those at increased risk for hemodynamic instability should be monitored appropriately. Etripamil may cause dizziness and/or syncope, especially in patients with a history of syncope and high-grade AV block or sinus node dysfunction, or those with a history of syncope during an episode of paroxysmal supraventricular tachycardia.